Protocatechuic acid reverses myocardial infarction mediated by β‐adrenergic agonist via regulation of Nrf2/HO‐1 pathway, inflammatory, apoptotic, and fibrotic events
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23270 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Li Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, HenanProvincial Chest Hospital, Zhengzhou University, Zhengzhou City, Henan Province, 450000, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Myocardial Infarction. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
Myocardial infarction (MI) is an instant ischemic death of cardiomyocytes that remains a major global cause of mortalities. MI is accompanied by oxidative, inflammatory, apoptotic, and fibrotic insults. Protocatechuic acid (PCA) is a polyphenolic compound with various potent biological activities. In this study, we explored the possible cardioprotective role of PCA against isoproterenol (ISO)‐mediated MI. Rats were either injected with ISO (85 mg/kg, subcutaneously) or pretreated with PCA (100 or 200 mg/kg, orally). PCA supplementation markedly normalized ISO‐induced disturbed cardiac function markers (creatine kinase‐MB, lactate dehydrogenase, and troponin T). Notably, PCA administration exerted remarkable increases in glutathione and its derived enzymes, superoxide dismutase, and catalase, as well as decreases in malondialdehyde and nitric oxide levels in the injured cardiac tissue. The molecular findings validated the augmented cellular antioxidative capacity by PCA via increasing the gene expressions of nuclear factor erythroid 2‐related factor 2 and heme oxygenase‐1. The cardioprotective efficacy of PCA extended to suppress cardiac inflammation as demonstrated by the decreased levels of tumor necrosis factor‐alpha, interleukin‐1 beta, and nuclear factor kappa B. Additionally, PCA prevented cardiomyocyte loss and fibrosis by decreasing Bax, caspase‐3, transforming growth factor‐β1 and matrix metalloproteinase‐9, and enhancing B‐cell lymphoma 2 and tissue inhibitors of metalloproteinase‐3. The cardiac histological screening further confirmed the PCA's protective action. The obtained data recommend PCA as an alternative therapeutic agent to attenuate the molecular, biochemical, and histological alterations associated with MI development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, HenanProvincial Chest Hospital, Zhengzhou University, Zhengzhou City, Henan Province, 450000, China.
- Department of Vasculocardiology, Xianyang Central Hospital, Xianyang, China.
- Department of Internal Medicine, The Second Affiliated Hospital of Xinxiang Medical College, Xinxiang City, Henan Province, China.
- Department of Cardiology, Chifeng Municipal Hospital, Chifeng City, China.
- The First Department of Cardiology, The Second Affiliated Hospital of GuiZhou Medical University, Kaili City, Guizhou Province, China.
- Basic Medical Science, Histopathology Department, National Organization for Drug Control and Research, Giza, Egypt.
Zitieren
APA
Li, L., Ma, H., Zhang, Y., Jiang, H., Xia, B., Sberi, H. A., Elhefny, M. A., Lokman, M. S., & Kassab, R. B. (2023). Protocatechuic acid reverses myocardial infarction mediated by β‐adrenergic agonist via regulation of Nrf2/HO‐1 pathway, inflammatory, apoptotic, and fibrotic events. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23270
Vancouver
Li L, Ma H, Zhang Y, Jiang H, Xia B, Sberi HA, et al. Protocatechuic acid reverses myocardial infarction mediated by β‐adrenergic agonist via regulation of Nrf2/HO‐1 pathway, inflammatory, apoptotic, and fibrotic events. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23270
BibTeX
@article{Li2023,
author = {Li, Li and Ma, Hua and Zhang, Yichong and Jiang, Haitao and Xia, Bihua and Sberi, Hassan Al and Elhefny, Mohamed A and Lokman, Maha S and Kassab, Rami B},
title = {Protocatechuic acid reverses myocardial infarction mediated by β‐adrenergic agonist via regulation of Nrf2/HO‐1 pathway, inflammatory, apoptotic, and fibrotic events},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23270}
}
EUVIMED